Gunnstein Bakland
Kristine Røren Nordén,
Anna Fryxelius,
Ingrid Fjeldheim Bånerud,
Gunnstein Bakland,
Tore Voksø,
Mona Larsen
et al.:
Mapping the future: identifying research priorities in rheumatoid arthritis with the James Lind Alliance approach
Gudrun David Sigmo,
Solveig Hauge,
Hanne Brit Hetland,
Marianne Wallenius,
Maria Boge Lauvsnes,
Kjell Åsmund Blix Salvesen
et al.:
Men with psoriatic arthritis, rheumatoid arthritis and axial spondylarthritis have more children and at an earlier age than matched controls: results from a nationwide cohort
Imane Bardan,
Till Uhlig,
Joseph Sexton,
Tore Kristian Aaserud Kvien,
Gunnstein Bakland,
Mielnik Pawel
et al.:
Health-related Quality of Life in DMARD-treated adults with Juvenile Idiopathic Arthritis Compared to Rheumatoid Arthritis and the General Population
Inger Jorid Berg,
Eirik Kristianslund,
Anne Therese Tveter,
Joseph Sexton,
Gunnstein Bakland,
Laure Gossec
et al.:
Remote monitoring or patient-initiated care in axial spondyloarthritis: a 3-armed randomised controlled noninferiority trial
Magnhild Hammersland Dagestad,
Nils Vetti,
Lars Christian Haugli Bråten,
Elisabeth Gjefsen,
Lars Grøvle,
Kristina Gervin
et al.:
Modic Change Edema in Chronic Low Back Pain Treated with Infliximab or Placebo: The BackToBasic Trial
Elisabeth Gjefsen,
Lars Christian Haugli Bråten,
Erica Ponzi,
Magnhild Hammersland Dagestad,
Gunn Hege Marchand,
Thomas Istvan Edelsvärd Kadar
et al.:
Efficacy of a Tumor Necrosis Factor Inhibitor in Chronic Low-Back Pain With Modic Type 1 Changes: A Randomized Controlled Trial
Kaja Eriksrud Kjørholt,
Nina Paulshus Sundlisæter,
Anna-Birgitte Aga,
Joseph Sexton,
Inge Christoffer Olsen,
Åse S. Lexberg
et al.:
Three-Year Results of Tapering Tumor Necrosis Factor Inhibitor to Withdrawal Compared to Stable Tumor Necrosis Factor Inhibitor Among Patients With Rheumatoid Arthritis in Sustained Remission: A Multicenter Randomized Trial
Håvard Halland Fretheim,
Imon Shoumitra Barua,
Gunnstein Bakland,
Alvilde Sofie Strand Dhainaut,
Anne Kristine Hjorteseth Halse,
Maylen Carstens Nordgård
et al.:
Faecal microbiota transplantation in patients with systemic sclerosis and lower gastrointestinal tract symptoms in Norway (ReSScue): a phase 2, randomised, double-blind, placebo-controlled trial
Katarzyna Weronika Łosińska,
Are Hugo Pripp,
Gunnstein Bakland,
Bjørg Tilde Svanes Fevang,
Lene Kristin Brekke,
Ada Wierød
et al.:
Comparative Effectiveness and Persistence of SB4 and Reference Etanercept in Patients With Psoriatic Arthritis in Norway
pål Nicolay Rydning,
Hege Linnerud,
JALAL MIRZAMOHAMMADI,
Tor Brommeland,
Pål Andre Rønning,
Magnus Mejlænder-Evjensvold
et al.:
Decreasing incidence of cervical spine fractures in patients with ankylosing spondylitis: a population-based study in Southeast Norway
Sella Aarrestad Provan,
F. Ahlfors,
Gunnstein Bakland,
Yi Hu,
Eirik Kristianslund,
Eirik Ikdahl
et al.:
A validation of register-derived diagnoses of interstitial lung disease in patients with inflammatory arthritis: data from the NOR-DMARD study
Emil E. Kvernberg Thomassen,
Inger Jorid Berg,
Eirik Kristianslund,
Anne Therese Tveter,
Gunnstein Bakland,
Laure Gossec
et al.:
Patients with axial spondyloarthritis reported willingness to use remote care and showed high adherence to electronic patient-reported outcome measures: an 18-month observational study
Kaja Eriksrud Kjørholt,
Nina Paulshus Sundlisæter,
Anna-Birgitte Aga,
Joseph Sexton,
Inge Christoffer Olsen,
Hallvard Fremstad
et al.:
Effects of tapering conventional synthetic disease-modifying antirheumatic drugs to drug-free remission versus stable treatment in rheumatoid arthritis (ARCTIC REWIND): 3-year results from an open-label, randomised controlled, non-inferiority trial
Gudrun David Sigmo,
Solveig Hauge,
Karl Ove Hufthammer,
Marianne Wallenius,
Kjell Åsmund Blix Salvesen,
Anne Kjersti Nesje Daltveit
et al.:
Male patients with inflammatory joint diseases are less likely than controls to be childless: Results from a Norwegian population-based cohort study of 10 865 patients
Alen Brkic,
Andreas P Diamantopoulos,
Mari Hoff,
Espen A. Haavardsholm,
Bjørg Tilde Svanes Fevang,
Lene Kristin Brekke
et al.:
Exploring the impact of the national tender system on the use of costly drugs treating rheumatoid arthritis patients in ten rheumatology centers in Norway (2010–2019)
Anne Christine Bull Haaversen,
Lene Kristin Brekke,
Gunnstein Bakland,
Erik Rødevand,
Geirmund Myklebust,
Andreas P Diamantopoulos
:
Norwegian society of rheumatology recommendations on diagnosis and treatment of patients with giant cell arteritis
Mikkel Østergaard,
Ronald F Van Vollenhoven,
Anna Rudin,
Merete Lund Hetland,
Marte Schrumpf,
Dan C Nordström
et al.:
Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis: 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial
Inger Jorid Berg,
Anne Therese Tveter,
Gunnstein Bakland,
Sarah Hakim,
Eirik Kristianslund,
Siri Lillegraven
et al.:
Follow-Up of Patients With Axial Spondyloarthritis in Specialist Health Care With Remote Monitoring and Self-Monitoring Compared With Regular Face-to-Face Follow-Up Visits (the ReMonit Study): Protocol for a Randomized, Controlled Open-Label Noninferiority Trial
Glenn Haugeberg,
Gunnstein Bakland,
Erik Rødevand,
Inger Johanne Widding Hansen,
Andreas P Diamantopoulos,
Are Hugo Pripp
:
Effectiveness and Persistence in SB4- and Reference Etanercept–Treated Rheumatoid Arthritis Patients in Ordinary Clinical Practice in Norway
Jens Vikse,
Øyvind Midtvedt,
Bjørg Tilde Svanes Fevang,
Torhild Oddveig Garen,
Øyvind Palm,
Marianne Wallenius
et al.:
Differential sensitivity of the 2020 revised comprehensive diagnostic criteria and the 2019 ACR/EULAR classification criteria across IgG4-related disease phenotypes: results from a Norwegian cohort
Siri Lillegraven,
Nina Paulshus Sundlisæter,
Anna-Birgitte Aga,
Joseph Sexton,
Inge Christoffer Olsen,
Åse Lexberg
et al.:
Effect of tapered versus stable treatment with tumour necrosis factor inhibitors on disease flares in patients with rheumatoid arthritis in remission: a randomised, open label, non-inferiority trial
Mielnik Pawel,
Joseph Sexton,
Karen Minde Fagerli,
Gunnstein Bakland,
Yi Hu,
Eirik Kristianslund
et al.:
Discontinuation rate of sulfasalazine, leflunomide and methotrexate due to adverse events in a real-life setting (NOR-DMARD)
Magnhild Hammersland Dagestad,
Nils Vetti,
Per M Kristoffersen,
John Anker Henrik Zwart,
Kjersti Storheim,
Gunnstein Bakland
et al.:
Apparent diffusion coefficient values in Modic changes – interobserver reproducibility and relation to Modic type
Alen Brkic,
Andreas P Diamantopoulos,
Espen A. Haavardsholm,
Bjørg Tilde Svanes Fevang,
Lene Kristin Brekke,
Liz Paucar Loli
et al.:
Exploring drug cost and disease outcome in rheumatoid arthritis patients treated with biologic and targeted synthetic DMARDs in Norway in 2010–2019 – a country with a national tender system for prescription of costly drugs
Imane Bardan,
Karen Minde Fagerli,
Joseph Sexton,
Tore Kristian Aaserud Kvien,
Gunnstein Bakland,
Mielnik Pawel
et al.:
Treatment Response to Tumor Necrosis Factor Inhibitors and Methotrexate Monotherapy in Adults With Juvenile Idiopathic Arthritis: Data From NOR-DMARD
Anna-Maria Hoffmann-Vold,
Håvard Halland Fretheim,
Vikas Kumar Sarna,
Imon Shoumitra Barua,
Maylen Carstens Nordgård,
Oliver Distler
et al.:
Safety and efficacy of faecal microbiota transplantation by Anaerobic Cultivated Human Intestinal Microbiome (ACHIM) in patients with systemic sclerosis: Study protocol for the randomised controlled phase II ReSScue trial
Siri Lillegraven,
Nina Beate Paulshus Sundlisæter,
Anna-Birgitte Aga,
Joseph Sexton,
Inge Christoffer Olsen,
Hallvard Fremstad
et al.:
Effect of Half-Dose vs Stable-Dose Conventional Synthetic Disease-Modifying Antirheumatic Drugs on Disease Flares in Patients with Rheumatoid Arthritis in Remission: The ARCTIC REWIND Randomized Clinical Trial
Ingrid Egeland Christensen,
Siri Lillegraven,
Mielnik Pawel,
Gunnstein Bakland,
Liz Paucar Loli,
Joseph Sexton
et al.:
Serious infections in patients with rheumatoid arthritis and psoriatic arthritis treated with tumour necrosis factor inhibitors: data from register linkage of the NOR-DMARD study
Christian Bindesbøll,
Marco Garrido-Cumbrera,
Gunnstein Bakland,
Hanne Dagfinrud
:
Obesity Increases Disease Activity of Norwegian Patients with Axial Spondyloarthritis: Results from the European Map of Axial Spondyloarthritis Survey
Aksel Thuv Nilsen,
Christine Karlsen,
Gunnstein Bakland,
Richard Watts,
Raashid Luqmani,
Wenche Koldingsnes
:
Increasing incidence and prevalence of ANCA-associated vasculitis in Northern Norway
Elisabeth Gjefsen,
Lars Christian Haugli Bråten,
Guro Løvik Goll,
Monica Wigemyr,
Nils Bolstad,
Morten Valberg
et al.:
The effect of infliximab in patients with chronic low back pain and Modic changes (the BackToBasic study): study protocol of a randomized, double blind, placebo-controlled, multicenter trial
Mielnik Pawel,
Joseph Sexton,
Elisabeth Lie,
Gunnstein Bakland,
Liz Paucar Loli,
Eirik Kristianslund
et al.:
Does Older Age have an Impact on Rituximab Efficacy and Safety? Results from the NOR-DMARD Register
Merete Lund Hetland,
Espen A. Haavardsholm,
Anna Rudin,
Dan C. Nordström,
Michael Nurmohamed,
Bjorn Gudbjornsson
et al.:
Active conventional treatment and three different biological treatments in early rheumatoid arthritis: Phase IV investigator initiated, randomised, observer blinded clinical trial
Brigitte Michelsen,
Joseph Sexton,
Ada Wierød,
Gunnstein Bakland,
Erik Rødevand,
Frode Krøll
et al.:
Four-year follow-up of inflammatory arthropathy patients treated with golimumab: Data from the observational multicentre NOR-DMARD study
Johannes Nossent,
Sylvia Sagen Johnsen,
Gunnstein Bakland
:
Disease Activity and Patient-Reported Health Measures in Relation to Cytokine Levels in Ankylosing Spondylitis
Johannes C. Nossent,
Sylvia Sagen-Johnsen,
Gunnstein Bakland
:
IL23R gene variants in relation to IL17A levels and clinical phenotype in patients with ankylosing spondylitis
Grunde Wibetoe,
Eirik Ikdahl,
Silvia Christin Hellerud Rollefstad,
Inge Christoffer Olsen,
Kjetil Bergsmark,
Tore Kristian Kvien
et al.:
Discrepancies in risk age and relative risk estimations of cardiovascular disease in patients with inflammatory joint diseases
Seyed Esmaeil Dorraji,
Aud-Malin Karlsson Hovd,
Premasany Kanapathippillai,
Gunnstein Bakland,
Gro Østli Eilertsen,
Stine Figenschau
et al.:
Mesenchymal stem cells and T cells in the formation of Tertiary Lymphoid Structures in Lupus Nephritis
Hege Lynum Pedersen,
Kjersti Daae Horvei,
Dhivya Thiyagarajan,
Gudrun Norby,
Natalya Seredkina,
Gabriella Moroni
et al.:
Lupus nephritis: low urinary DNase I levels reflect loss of
renal DNase I and may be utilized as a biomarker of
disease progression
Maja Skov Kragsnaes,
Benoit Thomas P. Gilbert,
Bjørk Khaliqi Sofíudóttir,
Christopher Michael Rooney,
Sebrina Maj Britt Hansen,
Daniele Mauro
et al.:
Efficacy and safety of microbiota-Targeted therapeutics in autoimmune and inflammatory rheumatic diseases: Protocol for a systematic review and meta-Analysis of randomised controlled trials
Anna Fryxelius,
Ingrid Fjeldheim Bånerud,
Kristine Røren Nordén,
Gunnstein Bakland,
Astrid Lunestad,
Kjersti Storheim
et al.:
Structured patient involvement in Rheumatoid Arthritis research: Identification and prioritization of key research questions using the James Lind Alliance method
2025 ARKIV
Jens Vikse,
Even Lillejordet,
Karen Minde Fagerli,
Gunnstein Bakland,
Espen A. Haavardsholm
:
Spondyloartritt: en oversikt
2024 ARKIV
Jens Vikse,
Gunnstein Bakland,
Inger Jorid Berg,
Espen A. Haavardsholm
:
Aksial spondyloartritt
2024 ARKIV
Kaja Eriksrud Kjørholt,
Nina Beate Paulshus Sundlisæter,
Anna-Birgitte Aga,
Joseph Sexton,
Inge Christoffer Olsen,
Tor Magne Madland
et al.:
OP0021 3-YEAR RESULTS OF TAPERING TNFi TO WITHDRAWAL COMPARED TO STABLE TNFi AMONG RHEUMATOID ARTHRITIS PATIENTS IN SUSTAINED REMISSION: A MULTICENTER RANDOMIZED TRIAL
Marte Schrumpf Heiberg,
Yogan Kisten,
Amirhossein Kazemi,
Hamed Rezaei,
Erik af Klint,
Maud-Kristine Aga Ljoså
et al.:
POS0474 ULTRASOUND REMISSION RATES AFTER 1 YEAR ARE HIGH IN EARLY RA PATIENTS ON INDUCTION TREATMENT: RESULTS FROM THE RANDOMIZED NORD-STAR TRIAL
Mikkel Østergaard,
Ronald van Vollenhoven,
Anna Rudin,
Merete L. Hetland,
Marte Schrumpf,
Dan Nordström
et al.:
CERTOLIZUMAB-PEGOL, ABATACEPT, TOCILIZUMAB OR ACTIVE CONVENTIONAL THERAPY IN EARLY RHEUMATOID ARTHRITIS: CLINICAL AND RADIOGRAPHIC 48-WEEKS RESULTS OF THE INVESTIGATOR-INITIATED RANDOMIZED NORD-STAR TRIAL
Siri Lillegraven,
Nina Paulshus Sundlisæter,
Anna-Birgitte Aga,
Joe Sexton,
Inge Christoffer Olsen,
Hallvard Fremstad
et al.:
Drug Free Remission in Rheumatoid Arthritis: Data from the Randomized Controlled ARCTIC REWIND Trial
Siri Lillegraven,
Nina Beate Paulshus Sundlisæter,
Anna-Birgitte Aga,
Joseph Sexton,
Inge Christoffer Olsen,
Åse Lexberg
et al.:
STABLE VERSUS TAPERED AND WITHDRAWN
TREATMENT WITH TUMOR NECROSIS FACTOR
INHIBITOR IN RHEUMATOID ARTHRITIS REMISSION (ARCTIC REWIND): A RANDOMISED, OPEN-LABEL, PHASE 4, NON-INFERIORITY TRIAL
Siri Lillegraven,
Nina Beate Paulshus Sundlisæter,
Anna-Birgitte Aga,
Joseph Sexton,
Inge Christoffer Olsen,
Hallvard Fremstad
et al.:
TAPERING OF CONVENTIONAL SYNTHETIC DISEASE MODIFYING ANTI-RHEUMATIC DRUGS IN SUSTAINED RHEUMATOID ARTHRITIS REMISSION: RESULTS FROM A RANDOMIZED CONTROLLED TRIAL
Hege Lynum Pedersen,
Kjersti Daae Horvei,
Dhivya Thiyagarajan,
Gudrun Norby,
Natalya Seredkina,
Gabriella Moroni
et al.:
LUPUS NEPHRITIS: SEVERELY REDUCED URINARY DNASE I LEVELS REFLECT LOSS OF RENAL DNASE I, DISEASE PROGRESSION AND MAY REDUCE THE NEED FOR RENAL BIOPSIES
2018 ARKIV
The 50 latest publications is shown on this page. See all publications in NVA here →